資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
The Union shall contribute to the costs incurred by the Member States relating to the application of the harmonised antimicrobial resistance monitoring in accordance with Implementing Decision 2013/652/EU on samples of poultry collected between 1 January and 31 December 2014, with a total maximum amount of EUR 1 407 585 to be financed from line 17 04 07 01.
The Union financial contribution:
(a)
shall be at a rate of 50 % of the costs incurred by each Member State to implement the monitoring referred to in Article 1 of Implementing Decision 2013/652/EU and performed by the competent authority;
(b)
shall not exceed the following:
(i)
EUR 8 for staff costs per caecal sampling;
(ii)
EUR 11 per E. coli isolation and identification;
(iii)
EUR 21,5 per Campylobacter isolation and identification;
(iv)
EUR 15 per antimicrobial susceptibility testing (AST) of each Salmonella or E. coli isolate;
(v)
EUR 15 per AST of each Campylobacter isolate;
(vi)
EUR 17,5 per characterisation and classification of Salmonella or E. coli isolates showing resistance to third-generation cephalosporins and meropenem;
(vii)
EUR 22 per Salmonella serotyping;
(viii)
the maximum amounts indicated in Annex I;
(c)
only the costs indicated in Annex II shall be eligible for contribution.
1. The Union contribution is subject to the following conditions:
(a)
by 31 May 2015, the Member States have provided to the European Food Safety Authority who was mandated for this task by the European Commission, with a technical report covering at least the information requested in Part B of the Annex to Implementing Decision 2013/652/EU;
(b)
by 31 May 2015, the Member States have provided the Commission, in electronic form, with a financial report according to the format laid out in Annex III to this Decision. In order to be eligible for funding, the expenditure incurred must have been paid before the submission of the claim. The supporting documents evidencing all the expenditure referred to in the financial report shall be sent to the Commission on request only.
2. The Commission may reduce the amount of the contributions referred to in Annex I in cases where the conditions referred to in paragraph 1 of this Article are not met, having regard to the nature and gravity of the non-compliance and to the potential financial loss for the Union.
For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro. When a Member State’s expenditure is in a currency other than euro, the Member State shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned.
This Decision constitutes a financing decision in the meaning of Article 84 of Regulation (EU, Euratom) No 966/2012.
This Decision is addressed to the Member States.
ANNEX I
Table 1
Member States
Number of
Caecal samples
Isolation/Identification & AST
AST Salmonella
Serotyping Salmonella
Characterisation and classification of resistant isolates
Campylobacter
E. coli
BE
850
170
170
550
550
150
BG
425
85
85
200
200
50
CZ
850
170
170
550
550
150
DK
850
170
170
250
250
100
DE
1 700
340
340
700
700
200
EE
425
85
85
100
100
50
IE
850
170
170
300
300
100
EL
850
170
170
450
450
100
ES
1 700
340
340
1 000
1 000
250
FR
1 700
340
340
800
800
250
HR
425
85
85
250
250
100
IT
1 700
340
340
800
800
250
CY
425
85
85
200
200
100
LV
425
85
85
100
100
50
LT
425
85
85
200
200
50
LU
425
85
85
100
100
50
HU
1 700
340
340
900
900
250
MT
425
85
85
100
100
50
NL
850
170
170
450
450
150
AT
1 700
340
340
550
550
200
PL
1 700
340
340
800
800
250
PT
1 700
340
340
500
500
200
RO
850
170
170
600
600
150
SI
425
85
85
200
200
50
SK
425
85
85
100
100
50
FI
850
170
170
50
50
50
SE
850
170
170
50
50
50
UK
1 700
340
340
800
800
250
Total
27 200
5 440
5 440
11 650
11 650
3 700
Table 2
Member States
Maximum reimbursement (EUR)
Caecal sampling
E. coli Isolation & identification
Campylobacter Isolation & identification
Salmonella serotyping
AST
Characterisation & classification resistant isolates
Total
Overheads included (7 %)
Salmonella + E. coli
Campylobacter
BE
6 800
2 200
14 800
14 700
10 800
2 600
2 700
54 600
58 422
BG
500
2 200
8 600
5 700
4 000
1 300
900
23 200
24 824
CZ
1 600
1 300
9 100
7 200
8 800
1 200
1 900
31 100
33 277
DK
6 800
2 200
18 300
9 300
6 300
2 600
1 800
47 300
50 611
DE
13 600
4 400
36 600
22 900
14 100
4 400
3 500
99 500
106 465
EE
400
1 000
3 300
4 100
2 200
1 100
200
12 300
13 161
IE
5 900
1 200
11 400
8 700
5 000
1 400
1 200
34 800
37 236
EL
2 000
2 200
14 900
7 700
8 500
2 600
1 300
39 200
41 944
ES
5 200
1 800
14 600
29 500
20 100
5 100
4 400
80 700
86 349
FR
13 600
4 400
36 600
25 100
17 100
4 100
4 400
105 300
112 671
HR
2 000
2 200
500
6 500
5 100
1 300
1 200
18 800
20 116
IT
13 600
4 400
25 000
16 500
12 200
3 700
2 700
78 100
83 567
CY
1 400
2 200
9 200
6 300
3 800
1 000
1 300
25 200
26 964
LV
700
900
3 400
3 900
1 600
800
500
11 800
12 626
LT
400
2 000
4 900
2 900
3 200
600
600
14 600
15 622
LU
3 400
2 200
9 200
4 100
2 800
1 300
900
23 900
25 573
HU
3 600
2 500
29 600
25 000
13 100
4 000
2 900
80 700
86 349
MT
1 300
500
5 500
3 500
2 000
700
900
14 400
15 408
NL
6 800
1 300
12 500
7 100
7 900
2 600
2 700
40 900
43 763
AT
13 600
4 400
36 600
17 000
13 400
5 100
3 500
93 600
100 152
PL
6 200
2 200
17 800
17 700
7 700
3 600
1 900
57 100
61 097
PT
4 400
3 900
36 600
18 500
5 600
2 100
1 700
72 800
77 896
RO
6 800
1 500
9 000
17 000
11 600
2 600
2 700
51 200
54 784
SI
3 400
1 900
9 200
5 200
2 700
1 300
900
24 600
26 322
SK
1 600
2 000
9 200
3 300
2 800
1 300
900
21 100
22 577
FI
6 800
1 900
8 300
0
3 300
2 300
900
23 500
25 145
SE
6 800
1 300
10 700
4 900
3 000
2 400
600
29 700
31 779
UK
13 600
3 600
36 600
25 100
17 100
5 100
4 400
105 500
112 885
Total
152 800
63 800
442 000
319 400
215 800
68 200
53 500
1 315 500
1 407 585
ANNEX II
ELIGIBILITY RULES
1. Laboratory costs
—
Staff costs shall be limited to actual attributable labour costs (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.
—
Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory designated by the competent authority.
—
Test kits, reagents and all other consumables shall only be reimbursed if used specifically in the performance of the following tests:
(i)
E. coli isolation and identification;
(ii)
Campylobacter isolation and identification;
(iii)
AST of Salmonella and E. coli isolates;
(iv)
AST of Campylobacter isolates;
(v)
Characterisation and classification of Salmonella and E. coli isolates showing resistance to third-generation cephalosporins and meropenem;
(vi)
Salmonella serotyping.
2. Sampling costs
Costs for sampling shall be limited to staff costs of work within the slaughterhouse for the actual attributable labour (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.
3. Overheads
A flat rate contribution of 7 % calculated on the basis of all direct eligible costs may be claimed.
4. The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.
ANNEX III
TEMPLATE FOR FINANCIAL REPORTS AS REFERRED TO IN ARTICLE 3(1)(B)
Reporting period: 2014
Member State: …
Reference number of Commission Implementing Decision providing a financial contribution from the Union: 2013/653/EU
Laboratory costs (total effective eligible costs)
E. coli isolation and identification
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Consumables (description)
Quantity
Unit cost (EUR)
Total (EUR)
…
…
Total (EUR)
Total nr of tests:
Unit cost per analysis (EUR)
Campylobacter isolation and identification
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Consumables (description)
Quantity
Unit cost (EUR)
Total (EUR)
…
…
Total (EUR)
Total nr of tests:
Unit cost per analysis (EUR)
AST Salmonella and E. coli isolates
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Consumables (description)
Quantity
Unit cost (EUR)
Total (EUR)
…
…
Total (EUR)
Total nr of tests:
Unit cost per analysis (EUR)
AST Campylobacter isolates
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Consumables (description)
Quantity
Unit cost (EUR)
Total (EUR)
…
…
Total (EUR)
Total nr of tests:
Unit cost per analysis (EUR)
Characterisation and classification of resistant isolates
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Consumables (description)
Quantity
Unit cost (EUR)
Total (EUR)
…
…
Total (EUR)
Total nr of tests:
Unit cost per analysis (EUR)
Salmonella serotyping
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Consumables (description)
Quantity
Unit cost (EUR)
Total (EUR)
…
…
Total (EUR)
Total nr of tests:
Unit cost per analysis (EUR)
Sampling costs (total effective eligible costs)
Staff category
Number of working hours
Rate (EUR per hour)
Total (EUR)
…
…
Total (EUR)
Total nr of samples:
Unit cost per sample (EUR)
Total expenditure for the coordinated control programme (real costs, VAT excluded) (EUR):
…
Declaration by the beneficiary
We certify that:
—
the expenditure listed above was incurred in the performance of tasks described in Implementing Decision 2013/652/EU and directly related to the implementation of the coordinated control plan for which financial support was granted according to Implementing Decision 2013/653/EU;
—
the expenditure was actually incurred, paid by the submission date of the current claim, accurately accounted for and eligible under the provisions of Implementing Decision 2013/653/EU;
—
all supporting documents supporting for the costs are available for audit purposes;
—
no other contribution from the Union was requested for this coordinated control plan.
Date: …
Person responsible: …
Signature: …
2013/653/EU: Commission Implementing Decision of 12 November 2013 as regards a Union financial aid towards a coordinated control plan for antimicrobial resistance monitoring in zoonotic agents in 2014 (notified under document C(2013) 7289) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32013D0653
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源：EUR-Lex·整理提供：法律人 LawPlayer· lawplayer.com